162 related articles for article (PubMed ID: 19401829)
1. Normal growth and development in mice over-expressing the CCN family member WISP3.
Nakamura Y; Cui Y; Fernando C; Kutz WE; Warman ML
J Cell Commun Signal; 2009 Jun; 3(2):105-13. PubMed ID: 19401829
[TBL] [Abstract][Full Text] [Related]
2. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.
Nakamura Y; Weidinger G; Liang JO; Aquilina-Beck A; Tamai K; Moon RT; Warman ML
J Clin Invest; 2007 Oct; 117(10):3075-86. PubMed ID: 17823661
[TBL] [Abstract][Full Text] [Related]
3. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice.
Kutz WE; Gong Y; Warman ML
Mol Cell Biol; 2005 Jan; 25(1):414-21. PubMed ID: 15601861
[TBL] [Abstract][Full Text] [Related]
4. Directed differentiation of human pluripotent stem cells into articular cartilage reveals effects caused by absence of
Li C; Ribes MA; Raftery R; Nwoko U; Warman ML; Craft AM
bioRxiv; 2023 Apr; ():. PubMed ID: 37066225
[TBL] [Abstract][Full Text] [Related]
5. A Wisp3 Cre-knockin allele produces efficient recombination in spermatocytes during early prophase of meiosis I.
Hann S; Kvenvold L; Newby BN; Hong M; Warman ML
PLoS One; 2013; 8(9):e75116. PubMed ID: 24040393
[TBL] [Abstract][Full Text] [Related]
6. Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia.
Yu Y; Hu M; Xing X; Li F; Song Y; Luo Y; Ma H
Mol Med Rep; 2015 Jul; 12(1):419-25. PubMed ID: 25738435
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.
Hurvitz JR; Suwairi WM; Van Hul W; El-Shanti H; Superti-Furga A; Roudier J; Holderbaum D; Pauli RM; Herd JK; Van Hul EV; Rezai-Delui H; Legius E; Le Merrer M; Al-Alami J; Bahabri SA; Warman ML
Nat Genet; 1999 Sep; 23(1):94-8. PubMed ID: 10471507
[TBL] [Abstract][Full Text] [Related]
8. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes.
Sen M; Cheng YH; Goldring MB; Lotz MK; Carson DA
Arthritis Rheum; 2004 Feb; 50(2):488-97. PubMed ID: 14872491
[TBL] [Abstract][Full Text] [Related]
9. Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA).
Yang Y; Liao E
Med Hypotheses; 2007; 68(6):1406-10. PubMed ID: 17363178
[TBL] [Abstract][Full Text] [Related]
10. [Clinical diagnosis and WISP3 gene mutation analysis for progressive pseudorheumatoid dysplasia].
Ye J; Zhang HW; Wang T; Cao LF; Qiu WJ; Han LS; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):194-8. PubMed ID: 20426955
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia.
Dalal A; Bhavani G SL; Togarrati PP; Bierhals T; Nandineni MR; Danda S; Danda D; Shah H; Vijayan S; Gowrishankar K; Phadke SR; Bidchol AM; Rao AP; Nampoothiri S; Kutsche K; Girisha KM
Am J Med Genet A; 2012 Nov; 158A(11):2820-8. PubMed ID: 22987568
[TBL] [Abstract][Full Text] [Related]
12. Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): Identification of two WISP3 mutations, one previously unreported.
Montané LS; Marín OR; Rivera-Pedroza CI; Vallespín E; Del Pozo Á; Heath KE
Am J Med Genet A; 2016 Jun; 170(6):1595-9. PubMed ID: 26991965
[TBL] [Abstract][Full Text] [Related]
13.
Sailani MR; Chappell J; Jingga I; Narasimha A; Zia A; Lynch JL; Mazrouei S; Bernstein JA; Aryani O; Snyder MP
Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092958
[TBL] [Abstract][Full Text] [Related]
14. A novel compound WISP3 mutation in a Chinese family with progressive pseudorheumatoid dysplasia.
Luo H; Shi C; Mao C; Jiang C; Bao D; Guo J; Du P; Wang Y; Liu Y; Liu X; Song B; Xu Y
Gene; 2015 Jun; 564(1):35-8. PubMed ID: 25794430
[TBL] [Abstract][Full Text] [Related]
15. Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis.
Cheon H; Boyle DL; Firestein GS
J Rheumatol; 2004 Nov; 31(11):2106-14. PubMed ID: 15517620
[TBL] [Abstract][Full Text] [Related]
16. Novel WISP3 mutations causing spondyloepiphyseal dysplasia tarda with progressive arthropathy in two unrelated Chinese families.
Liu L; Li N; Zhao Z; Li W; Xia W
Joint Bone Spine; 2015 Mar; 82(2):125-8. PubMed ID: 25553839
[TBL] [Abstract][Full Text] [Related]
17. WISP3-IGF1 interaction regulates chondrocyte hypertrophy.
Repudi SR; Patra M; Sen M
J Cell Sci; 2013 Apr; 126(Pt 7):1650-8. PubMed ID: 23424195
[TBL] [Abstract][Full Text] [Related]
18. A homozygous recurring mutation in WISP3 causing progressive pseudorheumatoid arthropathy.
Temiz F; Ozbek MN; Kotan D; Sangun O; Mungan NO; Yuksel B; Topaloglu AK
J Pediatr Endocrinol Metab; 2011; 24(1-2):105-8. PubMed ID: 21528827
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization in a cohort of patients with progressive pseudorheumatoid dysplasia.
El Dessouki D; Amr K; Kholoussi N; Rady HM; Temtamy SA; Abdou MMS; Aglan M
Am J Med Genet A; 2023 Sep; 191(9):2329-2336. PubMed ID: 37377052
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation.
Zhou HD; Bu YH; Peng YQ; Xie H; Wang M; Yuan LQ; Jiang Y; Li D; Wei QY; He YL; Xiao T; Ni JD; Liao EY
J Mol Med (Berl); 2007 Sep; 85(9):985-96. PubMed ID: 17483925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
